CN101357184A - Chinese traditional medicine for treating hepatosis and preparation method thereof - Google Patents
Chinese traditional medicine for treating hepatosis and preparation method thereof Download PDFInfo
- Publication number
- CN101357184A CN101357184A CNA2008101411015A CN200810141101A CN101357184A CN 101357184 A CN101357184 A CN 101357184A CN A2008101411015 A CNA2008101411015 A CN A2008101411015A CN 200810141101 A CN200810141101 A CN 200810141101A CN 101357184 A CN101357184 A CN 101357184A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- crude drug
- hepatopathy
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention pertains to the field of Chinese traditional medicine, in particular to a traditional Chinese medicine used for treating hepatopathy and a preparation method thereof. The traditional Chinese medicine is made of the following bulk drugs: capillary wormwood herb, giant knotweed, spreading hedyotis herb, red sage root, red peony root, nutagrass flatsedge rhizome, wolfberry fruit and ginseng. The traditional Chinese medicine has the advantages of simple formula, definite treatment effect, few toxic and side effects as will as high cure rate and quick effect. The cure rate of the traditional medicine is over 98% for common hepatitis A and over 80% for hepatitis B and other hepatic diseases.
Description
(1) technical field
The invention belongs to motherland's medical domain, particularly a kind of Chinese medicine for the treatment of hepatopathy and preparation method thereof.
(2) background technology
Hepatopathy is by a kind of disease that causes liver and gallbladder functional disorder and pathologic to change under the multiple factor effects such as diseases caused by exogenous pathogenic factor internal injury.Diseases caused by exogenous pathogenic factor mainly be experience the epidemic disease caused by damp-heat pathogen poison go into from table in aquatic weeds steam and cause in liver and gall that suffocating of liver and gall is unfavorable, the excessive jaundice that causes of bile, for a long time strongly fragrant change of epidemic disease caused by damp-heat pathogen poison causes qi depression to blood stasis to form chronic hepatopathy.Internal injury mainly is monophagia plumpness or pure wine, gives birth to humidogene heat, and damp and hot strongly fragrant resistance, the not normal liver and gall of involving of spleen fortune form this disease, moreover prolonged illness impairing the liver, deficiecny of liver-YIN, the liver pulse are lost to support and also can be caused this disease.Have plenty of be in a very depressed state, rage impairing the liver, the liver losing its smoothly moving state, QI and blood resistance network cause this disease.
The sickness rate height of hepatopathy, infectiousness are strong, are very big threats to people's life and health.The medicament categories of treatment hepatopathy is various at present, and some also has no small toxic and side effects, but effect is unsatisfactory, has brought great misery to the patient.
(3) summary of the invention
The object of the present invention is to provide a kind of Chinese medicine for the treatment of hepatopathy and preparation method thereof, the medicament toxic and side effects is little, and therapeutic effect is good.
The technical solution used in the present invention is as follows:
A kind of Chinese medicine for the treatment of hepatopathy is characterized in that being made by following bulk drugs:
Herba Artemisiae Scopariae 10-40 Rhizoma Polygoni Cuspidati 5-25 Hedyotidis Diffusae 10-40 Radix Salviae Miltiorrhizae 5-25 Radix Paeoniae Rubra 5-25 Rhizoma Cyperi 5-25 Fructus Lycii 5-25 Radix Ginseng 5-25.
Further, described crude drug is composed as follows:
Herba Artemisiae Scopariae 15-25 Rhizoma Polygoni Cuspidati 5-15 Hedyotidis Diffusae 15-25 Radix Salviae Miltiorrhizae 5-15 Radix Paeoniae Rubra 5-15 Rhizoma Cyperi 5-15 Fructus Lycii 5-15 Radix Ginseng 5-15.
Concrete, described crude drug is composed as follows:
Herba Artemisiae Scopariae 20 Rhizoma Polygoni Cuspidati 10 Hedyotidis Diffusaes 20 Radix Salviae Miltiorrhizaes 10 Radix Paeoniae Rubra 10 Rhizoma Cyperis 10 Fructus Lycii 10 Radix Ginsengs 10.
Described Chinese medicine can be made into receivable dosage form on any pharmaceutics, preferably makes capsule or oral liquid.
The preparation method of capsule is as follows: get each crude drug in proportion, be ground into and lastly be in harmonious proportion with Mel, incapsulate after the drying and make capsule.
The preparation method of oral liquid is as follows: get each crude drug in proportion, remove slag behind the decocting, get supernatant after leaving standstill and make oral liquid.
In the crude drug, Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis, Rhizoma Polygoni Cuspidati, the detoxifcation of Hedyotidis Diffusae jaundice eliminating, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra blood circulation promoting and blood stasis dispelling, Rhizoma Cyperi depressed liver-energy dispersing and QI regulating; The Radix Ginseng QI invigorating; Fructus Lycii yin nourishing benefit is smart, and all medicines share plays clearing away heat-damp and promoting diuresis altogether, jaundice eliminating detoxifcation, blood circulation promoting and blood stasis dispelling, depressed liver-energy dispersing and QI regulating, the merit of Replenishing QI and nourishing YIN.
Described Chinese medicine suit hepatitis A, hepatitis B, hepatitis C, liver cirrhosis, hepatic ascites etc.When taking, every day, 10g divided 2-3 clothes down.
The present invention has following advantage with respect to prior art:
Chinese medicine preparation of the present invention is simple, and therapeutic effect is definite, and toxic and side effects is little, and the high instant effect of cure rate, and general hepatitis A cure rate is more than 98%, and hepatitis B and other hepatopathy cure rates are more than 80%.
(4) specific embodiment:
Below with specific embodiment technical scheme of the present invention is described, but protection scope of the present invention is not limited thereto:
Embodiment 1
Crude drug is composed as follows, and unit is g:
Herba Artemisiae Scopariae 10 Rhizoma Polygoni Cuspidati 5 Hedyotidis Diffusaes 10 Radix Salviae Miltiorrhizaes 5 Radix Paeoniae Rubra 5 Rhizoma Cyperis 5 Fructus Lycii 5 Radix Ginsengs 5.
Get each crude drug, be ground into and lastly be in harmonious proportion, incapsulate after the drying and make capsule with Mel.
Embodiment 2
Crude drug is composed as follows, and unit is g:
Herba Artemisiae Scopariae 15 Rhizoma Polygoni Cuspidati 8 Hedyotidis Diffusaes 15 Radix Salviae Miltiorrhizaes 6 Radix Paeoniae Rubra 6 Rhizoma Cyperis 8 Fructus Lycii 5 Radix Ginsengs 8.
Get each crude drug, be ground into and lastly be in harmonious proportion, incapsulate after the drying and make capsule with Mel.
Embodiment 3
Crude drug is composed as follows, and unit is g:
Herba Artemisiae Scopariae 20 Rhizoma Polygoni Cuspidati 10 Hedyotidis Diffusaes 20 Radix Salviae Miltiorrhizaes 10 Radix Paeoniae Rubra 10 Rhizoma Cyperis 10 Fructus Lycii 10 Radix Ginsengs 10.
Get each crude drug, be ground into and lastly be in harmonious proportion, incapsulate after the drying and make capsule with Mel.
Embodiment 4
Crude drug is composed as follows, and unit is g:
Herba Artemisiae Scopariae 25 Rhizoma Polygoni Cuspidati 15 Hedyotidis Diffusaes 25 Radix Salviae Miltiorrhizaes 15 Radix Paeoniae Rubra 15 Rhizoma Cyperis 15 Fructus Lycii 15 Radix Ginsengs 15.
Get each crude drug, remove slag behind the decocting, get supernatant after leaving standstill and make oral liquid.
Embodiment 5
Crude drug is composed as follows, and unit is g:
Herba Artemisiae Scopariae 40 Rhizoma Polygoni Cuspidati 25 Hedyotidis Diffusaes 40 Radix Salviae Miltiorrhizaes 25 Radix Paeoniae Rubra 25 Rhizoma Cyperis 25 Fructus Lycii 25 Radix Ginsengs 25.
Get each crude drug, remove slag behind the decocting, get supernatant after leaving standstill and make oral liquid.
Model case:
1. Chen, the man, 25 years old, hepatitis B, hepatitis B great three positive, transaminase were higher, and medication 45 days transaminases reduce to normally, and great three positive is all turned out cloudy and is healed.
2. Yan, man, 35 years old; Before taking medicine, malaise is detested oil, bitter taste, yellow sclera, and the transaminase is all higher for the chemical examination serum bilirubin, and medication is looked into after 10 days again, and transaminase's bilirubin is all reduced to normally.Yellow sclera disappears, remission and healing.
3. paddy, the woman, 45 years old, low grade fever was weak, two side of body distensions, the little Huang of binocular, loss of appetite.Result of laboratory test, serum bilirubin the transaminase all increase, the hepatitis B great three positive; Be diagnosed as icterohepatitis type B.Medication is looked into after 5 months again, and the serum bilirubin transaminase all reduces to normally, and great three positive is also turned out cloudy in succession and healed.
Claims (6)
1. Chinese medicine for the treatment of hepatopathy is characterized in that being made by following bulk drugs:
Herba Artemisiae Scopariae 10-40 Rhizoma Polygoni Cuspidati 5-25 Hedyotidis Diffusae 10-40 Radix Salviae Miltiorrhizae 5-25 Radix Paeoniae Rubra 5-25 Rhizoma Cyperi 5-25 Fructus Lycii 5-25 Radix Ginseng 5-25.
2. the Chinese medicine of treatment hepatopathy as claimed in claim 1 is characterized in that described crude drug is composed as follows:
Herba Artemisiae Scopariae 15-25 Rhizoma Polygoni Cuspidati 5-15 Hedyotidis Diffusae 15-25 Radix Salviae Miltiorrhizae 5-15 Radix Paeoniae Rubra 5-15 Rhizoma Cyperi 5-15 Fructus Lycii 5-15 Radix Ginseng 5-15.
3. the Chinese medicine of treatment hepatopathy as claimed in claim 2 is characterized in that described crude drug is composed as follows:
Herba Artemisiae Scopariae 20 Rhizoma Polygoni Cuspidati 10 Hedyotidis Diffusaes 20 Radix Salviae Miltiorrhizaes 10 Radix Paeoniae Rubra 10 Rhizoma Cyperis 10 Fructus Lycii 10 Radix Ginsengs 10.
4. as the Chinese medicine of treatment hepatopathy as described in one of claim 1-3, it is characterized in that described crude drug makes capsule or oral liquid.
5. as the preparation method of Chinese medicine of treatment hepatopathy as described in one of claim 1-3, it is characterized in that getting each crude drug in proportion, be ground into and lastly be in harmonious proportion, incapsulate after the drying and make capsule with Mel.
6. as the preparation method of Chinese medicine of treatment hepatopathy as described in one of claim 1-3, it is characterized in that getting each crude drug in proportion, remove slag behind the decocting, get supernatant after leaving standstill and make oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101411015A CN101357184A (en) | 2008-08-22 | 2008-08-22 | Chinese traditional medicine for treating hepatosis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2008101411015A CN101357184A (en) | 2008-08-22 | 2008-08-22 | Chinese traditional medicine for treating hepatosis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101357184A true CN101357184A (en) | 2009-02-04 |
Family
ID=40329870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2008101411015A Pending CN101357184A (en) | 2008-08-22 | 2008-08-22 | Chinese traditional medicine for treating hepatosis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101357184A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102698143A (en) * | 2012-06-07 | 2012-10-03 | 黄芸 | Red/white peony root Chinese medicinal oral liquid for treating chronic hepatitis and preparation method |
| CN104547930A (en) * | 2015-01-12 | 2015-04-29 | 白忠可 | Heat-clearing and diuresis-promoting medicament for spleen-deficiency and dampness-heat type jaundice hepatitis and preparation method |
| CN104707107A (en) * | 2015-03-19 | 2015-06-17 | 吴玉生 | Traditional Chinese medicine for curing liver diseases |
| CN104922385A (en) * | 2015-06-30 | 2015-09-23 | 吕超 | Traditional Chinese medicine particulate agent for treating hepatic ascites |
| CN107929592A (en) * | 2017-12-14 | 2018-04-20 | 吴泽成 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
-
2008
- 2008-08-22 CN CNA2008101411015A patent/CN101357184A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102698143A (en) * | 2012-06-07 | 2012-10-03 | 黄芸 | Red/white peony root Chinese medicinal oral liquid for treating chronic hepatitis and preparation method |
| CN104547930A (en) * | 2015-01-12 | 2015-04-29 | 白忠可 | Heat-clearing and diuresis-promoting medicament for spleen-deficiency and dampness-heat type jaundice hepatitis and preparation method |
| CN104707107A (en) * | 2015-03-19 | 2015-06-17 | 吴玉生 | Traditional Chinese medicine for curing liver diseases |
| CN104922385A (en) * | 2015-06-30 | 2015-09-23 | 吕超 | Traditional Chinese medicine particulate agent for treating hepatic ascites |
| CN107929592A (en) * | 2017-12-14 | 2018-04-20 | 吴泽成 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301412A (en) | Traditional Chinese medicine composition for treating alcoholic liver | |
| CN102895456A (en) | Drug for treating polycystic ovarian syndrome | |
| CN102178850A (en) | Medicament for treating headache | |
| CN103341004A (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN101357184A (en) | Chinese traditional medicine for treating hepatosis and preparation method thereof | |
| CN103721190A (en) | Mixture for treating cystic acne | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN102940785A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN102988616B (en) | Chinese medicinal composition for treating anemia | |
| CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN101912524B (en) | Schisandra liver-benefiting capsules | |
| CN102988564B (en) | Traditional Chinese medicine composition for treating solar dermatitis | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN101757444A (en) | Orally administrated medicine for Chinese traditional treatment of thyroid nodule | |
| CN103330854A (en) | Traditional Chinese medicine composition for treating nasal hemorrhage | |
| CN103223139A (en) | Traditional Chinese medicinal composition for treating chronic ulcerative colitis | |
| CN102552729A (en) | Medicament for treating mesangial proliferative glomerulonephritis | |
| CN103007204B (en) | Chinese medicinal composition for treating hepatofibrosis | |
| CN102114211B (en) | Chinese herbal medicine for treating hepatopathy | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN103301429B (en) | Oral preparation for treating women dysmenorrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090204 |